Schematic representation of the artificial neural network developed to predict A) HBsAg seroclearance and B) HBsAg seroconversion. Ming-Hua Zheng Wai-Kay Seto Ke-Qing Shi Danny Ka-Ho Wong James Fung Ivan Fan-Ngai Hung Daniel Yee-Tak Fong John Chi-Hang Yuen Teresa Tong Ching-Lung Lai Man-Fung Yuen 10.1371/journal.pone.0099422.g001 https://plos.figshare.com/articles/figure/_Schematic_representation_of_the_artificial_neural_network_developed_to_predict_A_HBsAg_seroclearance_and_B_HBsAg_seroconversion_/1052242 <p>Note: qHBsAg, 3 years before baseline; HBV DNA, 3 years before baseline; qHBsAg reduction, 3 to 2 years before baseline; HBV DNA reduction, 3 to 2 years before baseline.</p> 2014-06-10 03:07:40 Gastroenterology and hepatology Liver diseases Infectious hepatitis Hepatitis B neural developed hbsag seroclearance